Cargando…
Patent strategy in pharmaceutical industry : are additional patents valuable? /
Dieses Buch untersucht die Lifecycle-Management-Strategien, die von Pharma-Unternehmen eingesetzt werden, um den Wert ihres Produktportfolios zu maximieren. Solche Strategien werden manchmal von Generika-Unternehmen als "evergreening" bezeichnet. Die Analyse erfolgt anhand zwei zufällig a...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Baden-Baden :
Nomos,
2014.
|
| Edición: | 1. Auflage. |
| Colección: | MIPLC studies ;
volume 20. |
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | JSTOROA_on1334650994 | ||
| 003 | OCoLC | ||
| 005 | 20231005004200.0 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 150529s2014 gw a ob 000 0 eng | ||
| 010 | |a 2020719250 | ||
| 040 | |a DLC |b eng |e pn |e rda |c DLC |d OCLCF |d YDXCP |d EBLCP |d DEBSZ |d JSTOR |d ICN |d SOI |d COO |d ERL |d TXR |d C6I |d VT2 |d UKKNU |d ABC |d YWS |d SFB |d OCLCO | ||
| 015 | |a 14,N07 |2 dnb | ||
| 019 | |a 873139289 |a 900414089 |a 1084339955 |a 1224916949 |a 1235843439 |a 1357389321 |a 1391453957 |a 1395788993 |a 1398104143 | ||
| 020 | |z 3848709910 | ||
| 020 | |z 9783848709915 | ||
| 020 | |a 9783845251288 | ||
| 020 | |a 384525128X | ||
| 029 | 1 | |a AU@ |b 000056062506 | |
| 029 | 1 | |a AU@ |b 000062534616 | |
| 029 | 1 | |a DEBSZ |b 431647895 | |
| 035 | |a (OCoLC)1334650994 |z (OCoLC)873139289 |z (OCoLC)900414089 |z (OCoLC)1084339955 |z (OCoLC)1224916949 |z (OCoLC)1235843439 |z (OCoLC)1357389321 |z (OCoLC)1391453957 |z (OCoLC)1395788993 |z (OCoLC)1398104143 | ||
| 037 | |a 22573/ctv931rkz |b JSTOR | ||
| 043 | |a e------ | ||
| 050 | 0 | 0 | |a KJE2751.M44 |
| 072 | 7 | |a LAW |x 014000 |2 bisacsh | |
| 082 | 0 | 4 | |a 346.04/86 |2 23 |
| 084 | |a 340 |2 sdnb | ||
| 049 | |a UAMI | ||
| 100 | 1 | |a Donghi, Monica, |e author. | |
| 245 | 1 | 0 | |a Patent strategy in pharmaceutical industry : |b are additional patents valuable? / |c Monica Donghi. |
| 250 | |a 1. Auflage. | ||
| 264 | 1 | |a Baden-Baden : |b Nomos, |c 2014. | |
| 300 | |a 1 electronic resource (84 pages ). | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a data file | ||
| 490 | 1 | |a MIPLC studies ; |v volume 20 | |
| 500 | |a Originally presented as author's thesis (LL.M.)--Munich Intellectual Property Law Center, 2012. | ||
| 504 | |a Includes bibliographical references (pages 77-84). | ||
| 588 | |a Description based on print version record; resource not viewed. | ||
| 505 | 0 | |a Acronyms and Abbreviations; I. Introduction; II. Background; A. Pharmaceutical Industry -- The Development of a New Drug.; B. New Drug Approval Regulations; C. Generic Drugs Approval.; III. Case Studies-Facts; A. Taxotere; 1. General; 2. Patent Portfolio; a) Process; b) Formulation; c) Combination Therapy; d) New Uses; e) Derivatives; 3. Use of Procedural Provisions: Supplementary Protection Certificates (SPCs)/Patent Term Extension; 4. Conclusion; B. Xalatan; 1. General; 2. Patent Portfolio; a) Process; b) Formulation; c) Combination Therapy; d) New Uses; e) Delivery Devices. | |
| 505 | 8 | |a F) Packaged Product3. Use of Procedural Provisions; a) Divisional of Basic Patent; b) Supplementary Protection; 4. Conclusion; IV. Discussion; A. Lifecycle Management: Criticism and Supports; B. Further Filing Strategy: Commercial Value; 1. Innovation Tracks; a) Formulations; b) Combinations; c) Process; d) New Uses; e) Delivery Devices; 2. Xalatan SPC Request: a Case for Competition Law?; C. Patent Strategy and Innovation; D. Summary: Taxotere v Xalatan; E. Conclusion and Suggestions; V. Final Remarks; List of works cited; Periodical Materials in English; Periodical Material in German. | |
| 505 | 8 | |a Non Periodical MaterialTable of books; Table of Cases; European Union; EPO Board of Appeal; France; Germany; Italy; United Kingdom; United States; Statutes; Speeches and Reports; Press release; Others. | |
| 520 | |a Dieses Buch untersucht die Lifecycle-Management-Strategien, die von Pharma-Unternehmen eingesetzt werden, um den Wert ihres Produktportfolios zu maximieren. Solche Strategien werden manchmal von Generika-Unternehmen als "evergreening" bezeichnet. Die Analyse erfolgt anhand zwei zufällig ausgewählter "Blockbuster"--Medikamente, Taxotere und Xalatan und konzentriert sich auf zwei dieser Strategien, nämlich die Produktverbesserung und die Produktlinienerweiterung. Reihe Munich Intellectual Property Law Center - MIPLC - Band 20. | ||
| 546 | |a English. | ||
| 590 | |a JSTOR |b Books at JSTOR Open Access | ||
| 590 | |a JSTOR |b Books at JSTOR All Purchased | ||
| 650 | 0 | |a Drugs |x Patents |x Economic aspects |z European Union countries. | |
| 650 | 0 | |a Patent medicines |x Law and legislation |z European Union countries. | |
| 650 | 0 | |a Patent medicines |z European Union countries |v Case studies. | |
| 650 | 0 | |a Drugs |x Patents. | |
| 650 | 6 | |a Médicaments |x Brevets d'invention. | |
| 650 | 6 | |a Médicaments |x Brevets d'invention |x Aspect économique |z Pays de l'Union européenne. | |
| 650 | 6 | |a Spécialités pharmaceutiques |z Pays de l'Union européenne |v Études de cas. | |
| 650 | 7 | |a LAW |x Commercial |x General. |2 bisacsh | |
| 650 | 7 | |a Patent medicines |2 fast | |
| 650 | 7 | |a Patent medicines |x Law and legislation |2 fast | |
| 651 | 7 | |a European Union countries |2 fast | |
| 653 | |a Markenrecht | ||
| 653 | |a Urheberrecht / Gewerblicher Rechtsschutz und Medienrecht | ||
| 653 | |a Gewerblicher Rechtsschutz | ||
| 655 | 7 | |a Case studies |2 fast | |
| 776 | 0 | 8 | |i Print version: |t Patent strategy in pharmaceutical industry |d Baden-Baden : Nomos, 2014. |z 9783848709915 |w (DLC) 2015372690 |
| 830 | 0 | |a MIPLC studies ; |v volume 20. | |
| 856 | 4 | 0 | |u https://jstor.uam.elogim.com/stable/10.2307/j.ctv941vfr |z Texto completo |
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL1645181 | ||
| 938 | |a Knowledge Unlatched |b KNOW |n 67e09acb-598b-474e-9cdc-c306b9ec02a6 | ||
| 938 | |a YBP Library Services |b YANK |n 11706076 | ||
| 994 | |a 92 |b IZTAP | ||